In the development of an IVT RNA vaccine, quality assurance is required

In the development of an IVT RNA vaccine, quality assurance is required ...

In vitro transcribed RNA vaccine development with Agilent Automated Electrophoresis InstrumentsThere is a need for rapid development and distribution of vaccinations. However, as the number of vaccine targets and production goals rise, so does the need for robust, reliable and rapid quality control methods. Download this whitepaper to learn more about:

  • Vaccine development
  • Vaccine production
  • Quality assurance in mRNA vaccine production

You may also like: